Current Context: CSIR-National Aerospace Laboratories (NAL) Bangalorehas developeda Non-Invasive BilevelPositive Airway Pressure (BiPAP) Ventilator.
- The BiPAP ventilator has been named as ‘SwasthVayu’.
- It has been developed in a record time of 36 days to treat COVID-19 patients.
- Its technical configuration is that it is a microcontroller-based precise closed-loop adaptive control systemwith a built-in biocompatible 3D printed manifoldcoupler with Highly Efficient Particulate Air Filter (HEPA Filter).
- It is designed with an unique features which help to alleviate the fear of the virus spread
- The features included in it are Spontaneous, CPAP, Timed, AUTO BIPAP modeswith provision to connect Oxygen concentratoror Enrichment unit externally.
- It has undergone various biomedical tests at NAL Health Centre and has been accredited by NABL in terms of safety and performance.
- SwasthVayu machine is simple to use without any specialized nursing, cost-effective, compact and configured with a majority of indigenous components.
- BIPAP Non-Invasive Ventilator has been developed with an externally connected Oxygen concentrator which will be ideal to treat moderate or mid-stage severe COVID-19 patients who do not require intubation and invasive ventilation.
Question:
Q.1 Which of the following organisation has developed BiPAP Non-Invasive ‘Swasth Vayu’ Ventilator in a record time of 36 days to treat COVID-19 patients?
a. DRDO
b. Bharat Biotech
c. IIT-Kharagpur
d. CSIR-National Aerospace Laboratories
a. DRDO
b. Bharat Biotech
c. IIT-Kharagpur
d. CSIR-National Aerospace Laboratories
